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Ourabilitytoprovideanalgesiaandsedation forchildrenhas
evolved over the past several years. We have progressed from
papoose boards to oral sucrose solutions to soothe babies
during procedures. Many procedures that were traditionally
performed in the operating room are being performed
in remote settings: inpatient wards, satellite units, and
emergency rooms. The delivery of pediatric sedation is no
longer restricted to a limited group of specialists, but instead
is delivered by specialists, and physicians as well as non-
physicians,intheﬁeldofanesthesia,hospitalmedicine,pedi-
atrics, intensive care medicine, dental medicine, emergency
medicine, and radiology. Some sedatives and analgesics have
been introduced to market within the past decade whereas
others, still in use, have existed for over a century.
The ability of infants to recognize pain was initially
underappreciated. Clinical and bench research, however,
have sensitized us to the newborn’s capacity to feel pain and
has, subsequently, laid the groundwork for ongoing research
into the pathophysiology of pain and clinical tools for
proper assessment [1, 2]. Acute pain management options
for children continue to evolve, encompassing all routes of
delivery: oral, rectal, topical, subcutaneous, mucosal, intra-
muscular, parenteral and recently intranasal. Some of the
recent introductions of this century include our appreciation
of the analgesic and sedative beneﬁts of oral sucrose in
newborns and the use of alternative delivery routes, such as
intranasal fentanyl for analgesia [3, 4]. There has also been
continued interest comparing the beneﬁts of nonsteroidal
anti-inﬂammatory medications to narcotics [5]. Despite the
advances in our knowledge and application of analgesics,
patient safety continues to be a concern, particularly as
unexpected adverse events, a morphine overdose in breast
milk of a mother taking codeine for example, continue to
occur [6].
Analgesia and sedation practices are not uniform; guide-
lines, policies, and protocols diﬀer among professional
organizations, provider groups, countries, institutions and
amongproviderswithinthesameinstitution.Theinabilityto
reachaconsensusonsafepracticeandappropriateguidelines
threatens our ability to provide safe, consistent care and
fuels debate and malcontent amongst and between some
specialties.
The magnitude of human and ﬁnancial cost of jeopardiz-
ing patient safety in sedation is large and adverse outcomes
should be rare. The numerical value of rare should not be
a percentage; for example, a 99.9% probability of having a
given outcome or 0.1% (1 in 1000) probability of a serious
adverse outcome as a result of sedation is not acceptable. An
acceptable aim for pediatric sedation should be “six sigma”
whichwillreduceadverseoutcometo3-4errorsperamillion
incidents [7].
Ensuring that the practice of pediatric analgesia and
sedation follows the same rigorous safety monitoring at all
times by all providers, and in any setting across the world is a
commonresponsibilitysharedbyhealthcareproviderscaring
for children.
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